AMGN vs CAH
By Alex · Tickerpine
Amgen Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | CAH |
|---|---|---|
| Price | $358.33 | $237.92 |
| Market cap | $193.39B | $55.72B |
| P/E ratio | 24.9 | 36.4 |
| ROE | 101.32% | — |
| Profit margin | 20.96% | 0.62% |
| Revenue growth | 5.80% | 11.00% |
| Dividend yield | 2.81% | 0.86% |
| Beta | 0.42 | 0.53 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs CAH in plain English
- AMGN is the bigger company — about 3.5× the market cap of CAH.
- AMGN is cheaper on earnings (P/E 24.9 vs 36.4).
- CAH is growing revenue faster (11% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 0.86%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.